Risk aversion and COVID‐19 vaccine hesitancy

B-Tier
Journal: Health Economics
Year: 2023
Volume: 32
Issue: 8
Pages: 1659-1669

Authors (5)

Anthony Lepinteur (Université du Luxembourg) Liyousew G. Borga Andrew E. Clark (not in RePEc) Claus Vögele (not in RePEc) Conchita D’Ambrosio (not in RePEc)

Score contribution per author:

0.402 = (α=2.01 / 5 authors) × 1.0x B-tier

α: calibrated so average coauthorship-adjusted count equals average raw count

Abstract

We here investigate the role of risk aversion in COVID‐19 vaccine hesitancy. The theoretical effect is ambiguous, as both COVID‐19 infection and vaccination side‐effects involve probabilistic elements. In large‐scale data covering five European countries, we find that vaccine hesitancy falls with risk aversion, so that COVID‐19 infection is perceived as involving greater risk than is vaccination.

Technical Details

RePEc Handle
repec:wly:hlthec:v:32:y:2023:i:8:p:1659-1669
Journal Field
Health
Author Count
5
Added to Database
2026-01-24